|
Autoantibodies Present in Chronic Hepatitis
C and Chronic Hepatitis B Viral Infections
| table 1. Incidence
of Antibodies to Defined Peptides Among HCV and HBV Patients |
|
| Peptide (kd) |
HCV Patients (%) (n = 24) |
HBV Patients (%) (n = 24) |
Controls (%) (n = 40) |
|
| p105 |
13 (54%) |
14 (58%) |
0 |
| p70 |
7 (29) |
10 (42) |
0 |
| p86 |
15 (63%) |
11 (46%) |
1 (3%) |
| p80 |
11 (46) |
8 (33) |
0 |
| p66 |
7 (29) |
5 (21) |
0 |
| p68 |
6 (25%) |
3 (13%) |
0 |
| p33 |
1 (4) |
1 (4) |
0 |
| p22 |
5 (21) |
2 (8) |
0 |
| p60 |
20 (83%) |
15 (63%) |
9 (23%) |
| p54 |
4 (17) |
6 (25%) |
0 |
| p52 |
5 (21) |
6 (25) |
0 |
| p50 |
7 (29%) |
7 (29%) |
0 |
| p43 |
7 (29) |
4 (17) |
0 |
| p38 |
2 (8%) |
0 |
0 |
| p19 |
5 (21) |
4 (17%) |
0 |
| p17 |
0 |
0 |
0 |
| p26 |
9 (38%) |
14 (58%) |
0 |
| p25 |
6 (25) |
4 (17) |
0 |
| p18 |
2 (8) |
2 (8) |
0 |
| p16 |
3 (13) |
9 (38) |
0 |
|
|
Abbreviations: HCV, hepatitis C virus; HBV, hepatitis
B virus.
|
|
|
